Cargando...
Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present)
INTRODUCTION: Anticoagulation without bleeding is an ideal goal in treating thrombosis, however, this goal has not been achieved. All current anticoagulants are associated with significant bleeding which limits their safe use. Genetic and pharmacological findings indicate that factor XIa is a key pl...
Guardado en:
| Publicado en: | Expert Opin Ther Pat |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515655/ https://ncbi.nlm.nih.gov/pubmed/31847619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543776.2020.1705783 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|